Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
6,750.00
-80.00 (-1.17%)
At close: Sep 16, 2025
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 58.23 billion as of September 19, 2025. Its market cap has decreased by -20.83% in one year.
Market Cap
58.23B
Enterprise Value
40.55B
Revenue
71.00B
Ranking
n/a
PE Ratio
36.64
Stock Price
6,750.00
Market Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 58.23B, a decrease of -16.51%. That is a compound annual growth rate of -0.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 58.23B | -5.26% |
Dec 30, 2024 | 61.46B | -21.97% |
Dec 28, 2023 | 78.77B | -19.25% |
Dec 29, 2022 | 97.55B | -44.18% |
Dec 30, 2021 | 174.75B | 62.58% |
Dec 30, 2020 | 107.49B | 56.83% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 520.34T |
SK hynix | 243.72T |
LG Energy Solution | 81.78T |
Samsung Biologics | 72.88T |
Hanwha Aerospace | 52.58T |
Hyundai Motor Company | 46.74T |
HD Hyundai Heavy Industries | 43.77T |
KB Financial Group | 42.75T |